23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia

[...]based on the systematic literature review and pooled data analysis,2 the authors' group reported that serotype replacement occurred in adult pneumococcal pneumonia cases following the vaccination of children with PCV7 in Japan, although there was a significant decrease (-18·1%, 95% CI −24·...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2017-07, Vol.17 (7), p.692-693
Main Authors: Tanimoto, Tetsuya, Kusumi, Eiji, Hosoda, Kazutaka, Hamaki, Tamae, Takahashi, Kenzo
Format: Article
Language:English
Subjects:
Adults
Children
Data analysis
Data processing
Immunization
Infectious diseases
Literature reviews
Pneumonia
Polysaccharides
Serotypes
Streptococcus infections
Vaccination
Vaccines
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3
cites cdi_FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3
container_end_page 693
container_issue 7
container_start_page 692
container_title The Lancet infectious diseases
container_volume 17
creator Tanimoto, Tetsuya
Kusumi, Eiji
Hosoda, Kazutaka
Hamaki, Tamae
Takahashi, Kenzo
description [...]based on the systematic literature review and pooled data analysis,2 the authors' group reported that serotype replacement occurred in adult pneumococcal pneumonia cases following the vaccination of children with PCV7 in Japan, although there was a significant decrease (-18·1%, 95% CI −24·6 to −11·5, p
doi_str_mv 10.1016/S1473-3099(17)30332-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1914291637</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309917303328</els_id><sourcerecordid>1912667187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3</originalsourceid><addsrcrecordid>eNqFkUtLAzEUhYMotlZ_glJwUxejeU2SWYkUX1Bwoa5DJnNHU6aTmswU-u-dTquLLhQu3Jvw3ZNwDkLnBF8TTMTNK-GSJQxn2YTIK4YZo4k6QMPumiecp_Kwn7fIAJ3EOMeYSIL5MRpQJVImGBuiGWXJylRQN-NlDe3CW2-tqcZLX62jsfbTBFfAeNWNroax-TCujvtsf6idOUVHpakinO36CL0_3L9Nn5LZy-Pz9G6WWC5Uk1iVpdIKKnJmVG5ZTgsoSyptUeKUYwAquckFJoClxBaUygsQOBPFpiiwEZpsdZfBf7UQG71w0UJVmRp8GzXJCKcZEUx26OUeOvdtqLvfacoFZ1xRxv-iOi0qhCRqo5VuKRt8jAFKvQxuYcJaE6w3oeg-FL1xXBOp-1C06vYuduptvoDid-snhQ643QLQmbZyEHS0DmoLhQtgG114988T357ZmxE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1912667187</pqid></control><display><type>article</type><title>23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia</title><source>ScienceDirect Journals</source><creator>Tanimoto, Tetsuya ; Kusumi, Eiji ; Hosoda, Kazutaka ; Hamaki, Tamae ; Takahashi, Kenzo</creator><creatorcontrib>Tanimoto, Tetsuya ; Kusumi, Eiji ; Hosoda, Kazutaka ; Hamaki, Tamae ; Takahashi, Kenzo</creatorcontrib><description>[...]based on the systematic literature review and pooled data analysis,2 the authors' group reported that serotype replacement occurred in adult pneumococcal pneumonia cases following the vaccination of children with PCV7 in Japan, although there was a significant decrease (-18·1%, 95% CI −24·6 to −11·5, p&lt;0·001) in the proportion of the PCV7-covered serotypes, there were significant increases in the proportions of serotypes covered by PCV13 but not by PCV7 (+9·9%, 3·3-16·4, p=0·003) and serotypes covered by...</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(17)30332-8</identifier><identifier>PMID: 28653633</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adults ; Children ; Data analysis ; Data processing ; Immunization ; Infectious diseases ; Literature reviews ; Pneumonia ; Polysaccharides ; Serotypes ; Streptococcus infections ; Vaccination ; Vaccines</subject><ispartof>The Lancet infectious diseases, 2017-07, Vol.17 (7), p.692-693</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Jul 1, 2017</rights><rights>2017. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3</citedby><cites>FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28653633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanimoto, Tetsuya</creatorcontrib><creatorcontrib>Kusumi, Eiji</creatorcontrib><creatorcontrib>Hosoda, Kazutaka</creatorcontrib><creatorcontrib>Hamaki, Tamae</creatorcontrib><creatorcontrib>Takahashi, Kenzo</creatorcontrib><title>23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>[...]based on the systematic literature review and pooled data analysis,2 the authors' group reported that serotype replacement occurred in adult pneumococcal pneumonia cases following the vaccination of children with PCV7 in Japan, although there was a significant decrease (-18·1%, 95% CI −24·6 to −11·5, p&lt;0·001) in the proportion of the PCV7-covered serotypes, there were significant increases in the proportions of serotypes covered by PCV13 but not by PCV7 (+9·9%, 3·3-16·4, p=0·003) and serotypes covered by...</description><subject>Adults</subject><subject>Children</subject><subject>Data analysis</subject><subject>Data processing</subject><subject>Immunization</subject><subject>Infectious diseases</subject><subject>Literature reviews</subject><subject>Pneumonia</subject><subject>Polysaccharides</subject><subject>Serotypes</subject><subject>Streptococcus infections</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkUtLAzEUhYMotlZ_glJwUxejeU2SWYkUX1Bwoa5DJnNHU6aTmswU-u-dTquLLhQu3Jvw3ZNwDkLnBF8TTMTNK-GSJQxn2YTIK4YZo4k6QMPumiecp_Kwn7fIAJ3EOMeYSIL5MRpQJVImGBuiGWXJylRQN-NlDe3CW2-tqcZLX62jsfbTBFfAeNWNroax-TCujvtsf6idOUVHpakinO36CL0_3L9Nn5LZy-Pz9G6WWC5Uk1iVpdIKKnJmVG5ZTgsoSyptUeKUYwAquckFJoClxBaUygsQOBPFpiiwEZpsdZfBf7UQG71w0UJVmRp8GzXJCKcZEUx26OUeOvdtqLvfacoFZ1xRxv-iOi0qhCRqo5VuKRt8jAFKvQxuYcJaE6w3oeg-FL1xXBOp-1C06vYuduptvoDid-snhQ643QLQmbZyEHS0DmoLhQtgG114988T357ZmxE</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Tanimoto, Tetsuya</creator><creator>Kusumi, Eiji</creator><creator>Hosoda, Kazutaka</creator><creator>Hamaki, Tamae</creator><creator>Takahashi, Kenzo</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia</title><author>Tanimoto, Tetsuya ; Kusumi, Eiji ; Hosoda, Kazutaka ; Hamaki, Tamae ; Takahashi, Kenzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adults</topic><topic>Children</topic><topic>Data analysis</topic><topic>Data processing</topic><topic>Immunization</topic><topic>Infectious diseases</topic><topic>Literature reviews</topic><topic>Pneumonia</topic><topic>Polysaccharides</topic><topic>Serotypes</topic><topic>Streptococcus infections</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanimoto, Tetsuya</creatorcontrib><creatorcontrib>Kusumi, Eiji</creatorcontrib><creatorcontrib>Hosoda, Kazutaka</creatorcontrib><creatorcontrib>Hamaki, Tamae</creatorcontrib><creatorcontrib>Takahashi, Kenzo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanimoto, Tetsuya</au><au>Kusumi, Eiji</au><au>Hosoda, Kazutaka</au><au>Hamaki, Tamae</au><au>Takahashi, Kenzo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2017-07</date><risdate>2017</risdate><volume>17</volume><issue>7</issue><spage>692</spage><epage>693</epage><pages>692-693</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><abstract>[...]based on the systematic literature review and pooled data analysis,2 the authors' group reported that serotype replacement occurred in adult pneumococcal pneumonia cases following the vaccination of children with PCV7 in Japan, although there was a significant decrease (-18·1%, 95% CI −24·6 to −11·5, p&lt;0·001) in the proportion of the PCV7-covered serotypes, there were significant increases in the proportions of serotypes covered by PCV13 but not by PCV7 (+9·9%, 3·3-16·4, p=0·003) and serotypes covered by...</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>28653633</pmid><doi>10.1016/S1473-3099(17)30332-8</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2017-07, Vol.17 (7), p.692-693
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_miscellaneous_1914291637
source ScienceDirect Journals
subjects Adults
Children
Data analysis
Data processing
Immunization
Infectious diseases
Literature reviews
Pneumonia
Polysaccharides
Serotypes
Streptococcus infections
Vaccination
Vaccines
title 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T19%3A47%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=23-valent%20pneumococcal%20polysaccharide%20vaccine%20against%20pneumococcal%20pneumonia&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Tanimoto,%20Tetsuya&rft.date=2017-07&rft.volume=17&rft.issue=7&rft.spage=692&rft.epage=693&rft.pages=692-693&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(17)30332-8&rft_dat=%3Cproquest_cross%3E1912667187%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-c8957c626b3a8bc3b2deff27cdf0540ee274ab601e0770ce88bde6096d96d92e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1912667187&rft_id=info:pmid/28653633&rfr_iscdi=true